Search for new drugs for treatment of tuberculosis

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 7, 2001, Pages 1943-1946

  Orme, I ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; NEW DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; BACTERIAL GROWTH; BONE MARROW; CONTROLLED STUDY; IC 50; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NOTE; PRIORITY JOURNAL; RADIOMETRY; TUBERCULOSIS;

ANIMALS; ANTITUBERCULAR AGENTS; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; HUMANS; MICE; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; NATIONAL INSTITUTES OF HEALTH (U.S.); TUBERCULOSIS; UNITED STATES;

EID: 0034956212     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.7.1943-1946.2001     Document Type: Note

References (19)

1. Evaluation of once-weekly therapy for tuberculosis using isoniazid plus rifamycins in the mouse aerosol infection model
2. Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium
3. Disseminated tuberculosis in interferon gamma gene-disrupted mice
4. Activities of several novel oxazolidinones against Mycobacterium tuberculosis in a murine model
5. Will DOTS do it? A reappraisal of tuberculosis control in countries with high rates of HIV infection
6. Consensus statement. Global burden of tuberculosis: Estimated incidence, prevalence, and mortality by country
7. In vitro and in vivo activities of moxifloxacin and clinafloxacin against Mycobacterium tuberculosis
8. In vitro and in vivo activities of levofloxacin against Mycobacterium tuberculosis
9. Low-dose aerosol infection model for testing drugs for efficacy against Mycobacterium tuberculosis
10. Disintegrating health services and resurgent tuberculosis in post-Soviet Tajikistan: An example of structural violence
11. Evaluation of rifapentine in long-term treatment regimens for tuberculosis in mice
12. Evaluation of rifalazil in a combination treatment regimen as an alternative to isoniazidrifampin therapy in a mouse tuberculosis model
13. Moxifloxacin (BAY12-8039), a new 8-methoxyquinolone, is active in a mouse model of tuberculosis
14. Vaccination against tuberculosis: Recent progress
15. Durable cure for tuberculosis: Rifalazil in combination with isoniazid in a murine model of Mycobacterium tuberculosis infection
16. A bone marrow-derived murine macrophage model for evaluating efficacy of antimycobacterial drugs under relevant physiological conditions
17. Comparison of activities of fluoroquinolones in murine macrophages infected with Mycobacterium tuberculosis
18. A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis
19. Determination of the minimal effective dosages of ofloxacin and sparfloxacin against M. leprae in the mouse foot pad system